Theravance Biopharma, Inc. (TBPH)
18.70
-0.22
(-1.14%)
USD |
NASDAQ |
Dec 31, 16:00
18.70
0.00 (0.00%)
After-Hours: 17:15
Theravance Biopharma Price: 18.70 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 34.79 |
| Perspective Therapeutics, Inc. | 2.745 |
| Skye Bioscience, Inc. | 0.7443 |
| FibroGen, Inc. | 8.68 |
| Myomo, Inc. | 0.9287 |
Price Related Metrics
| PE Ratio | 33.24 |
| PS Ratio | 11.73 |
| Price to Book Value | 4.071 |
| Price to Free Cash Flow | 3.871 |
| Earnings Yield | 3.01% |
| Market Cap | 947.32M |
| Normalized PE Ratio | 33.24 |